Health Canada Approves Otsuka and Lundbeck’s REXULTI

Read more

Dauntless Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Octreotide Formulation for Intranasal Delivery

Read more

Imprimis Pharmaceuticals Begins Dispensing from FDA-Registered 503B Outsourcing Facility

Read more

Takeda acquires Ariad Pharmaceuticals

Read more

Solasia and Lee’s Pharma Announce License, Promotion and Supply Agreement for episil

Read more

Mayne Pharma Launches Butalbital Acetaminophen Tablets in The United States

Read more

X-Chem Expands Collaboration with Janssen in Inflammatory Diseases

Read more

Catalent Completes Accucaps Acquisition

Read more

Vyome Biosciences Announces Top-Line Results from Phase 1 Study of VB-1953

Read more

FDA Approves Amgen’s Parsabiv (Etelcalcetide) for Secondary Hyperparathyroidism

Read more